EAM
CERE
Eventide Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-490,000
| Closed | -$20M | – | 196 |
|
|
2024
Q2 | $20M | Hold |
490,000
| – | – | 0.34% | 91 |
|
|
2024
Q1 | $20.7M | Hold |
490,000
| – | – | 0.32% | 92 |
|
|
2023
Q4 | $20.8M | Hold |
490,000
| – | – | 0.34% | 88 |
|
|
2023
Q3 | $10.7M | Hold |
490,000
| – | – | 0.19% | 120 |
|
|
2023
Q2 | $15.6M | Buy |
490,000
+178,000
| +57% | +$5.66M | 0.26% | 100 |
|
|
2023
Q1 | $7.61M | Buy |
+312,000
| New | +$7.61M | 0.14% | 121 |
|